The aim of the study is to describe the prescribing pattern of the differen...
Status
Completed
Location
Research Site
Start Date
2019-03-29
Trial ID
NCT03857178
Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Short Acting Beta-2 Agonist (SABA) Therapy Alone
PHASE2
The aim of this study is to assess and compare efficacy and safety of BI 54...
Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma
PHASE3
The primary objective of the study is to evaluate the long-term safety of f...
Two Inhalation Methods Using a Pressurized Metered Dose Inhaler With Valved Holding Chamber to Assess Improvement in Lung Function After SABA Administration in Bronchial Asthma
NA
Bronchial asthma is a chronic inflammatory disorder characterized by recurr...